Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biomerica (BMRA) EPS (Weighted Average and Diluted) (2016 - 2025)

Historic EPS (Weighted Average and Diluted) for Biomerica (BMRA) over the last 15 years, with Q4 2025 value amounting to -$0.45.

  • Biomerica's EPS (Weighted Average and Diluted) fell 65000.0% to -$0.45 in Q4 2025 from the same period last year, while for Nov 2025 it was -$2.49, marking a year-over-year increase of 2611.28%. This contributed to the annual value of -$2.16 for FY2025, which is 2380.02% up from last year.
  • Latest data reveals that Biomerica reported EPS (Weighted Average and Diluted) of -$0.45 as of Q4 2025, which was down 65000.0% from $0.0 recorded in Q3 2025.
  • Biomerica's 5-year EPS (Weighted Average and Diluted) high stood at $0.0 for Q3 2025, and its period low was -$2.57 during Q2 2024.
  • For the 5-year period, Biomerica's EPS (Weighted Average and Diluted) averaged around -$0.29, with its median value being -$0.12 (2021).
  • In the last 5 years, Biomerica's EPS (Weighted Average and Diluted) plummeted by 247000.0% in 2024 and then surged by 10012.03% in 2025.
  • Over the past 5 years, Biomerica's EPS (Weighted Average and Diluted) (Quarter) stood at -$0.09 in 2021, then crashed by 33.33% to -$0.12 in 2022, then increased by 25.0% to -$0.09 in 2023, then surged by 33.33% to -$0.06 in 2024, then crashed by 650.0% to -$0.45 in 2025.
  • Its last three reported values are -$0.45 in Q4 2025, $0.0 for Q3 2025, and -$0.67 during Q2 2025.